Valuation : Masimo Corporation

Market Cap 9.42B 8.11B 7.61B 6.96B 12.99B 891B 13.1B 90.01B 35.05B 455B 35.39B 34.61B 1,466B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.46B 7.94B 7.26B 13.55B 929B 13.66B 93.89B 36.57B 475B 36.91B 36.11B 1,529B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
3 months+0.65%
6 months+2.62%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 02/08/2026
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 09/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/06/26 Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
23/04/26 Exercice

Director

3,569 0.0068%
23/04/26 Exercice

Director

3,569 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+31.57%+58.42% 9.42B
+0.38%+0.20%+15.23%+22.97% 12.65B
-1.23%-2.75%+15.12%+25.31% 6.96B
-1.38%+16.84% - - 6.7B
-2.41%-8.83%+32.67%+20.52% 6.15B
+3.02%+0.33%-20.29%+49.15% 5.06B
+0.51%-2.20%-30.15%-23.01% 3.8B
-0.28%-1.52%+46.49%-18.07% 2.05B
-2.53%-3.50%-7.80%+128.85% 1.76B
+2.63%-1.26%+50.97%-14.15% 1.6B
Average -0.12%+1.16%+14.87%+27.78% 5.62B
Weighted average by Cap. -0.19%+1.98%+15.01%+29.76%

Financials

2024 2025
Net sales 2.09B 1.8B 1.69B 1.55B 2.89B 198B 2.91B 20B 7.79B 101B 7.86B 7.69B 326B 1.53B 1.31B 1.23B 1.13B 2.11B 144B 2.12B 14.58B 5.68B 73.76B 5.73B 5.61B 238B
Net income -305M -262M -246M -225M -420M -28.82B -424M -2.91B -1.13B -14.73B -1.14B -1.12B -47.44B -152M -130M -122M -112M -209M -14.32B -211M -1.45B -564M -7.32B -569M -557M -23.57B
Net Debt 668M 575M 540M 494M 922M 63.19B 929M 6.39B 2.49B 32.29B 2.51B 2.46B 104B 407M 350M 329M 301M 561M 38.47B 566M 3.89B 1.51B 19.66B 1.53B 1.5B 63.32B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock